NFE2L2 and breast cancer: Nrf2-ko mice have been found to be more sensitive to DMBA-induced mammary cancer than their wildtype counterparts [100], but little has been reported about the ability of chemopreventive agents to protect against mammary tumourigenesis in Nrf2-ko animals.